| Year |
Title |
Altmetric |
| 2022
|
PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice.
American Journal of Neuroradiology.
43:938-943.
2022
|
|
| 2022
|
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures.
Journal of Nuclear Medicine.
63:287-293.
2022
|
|
| 2021
|
Utility of 18F-fluciclovine PET/MRI for staging newly diagnosed high-risk prostate cancer and evaluating response to initial androgen deprivation therapy: A prospective single-arm pilot study.
American Journal of Roentgenology.
217:720-729.
2021
|
|
| 2021
|
Production of [89Zr]Oxinate4 and cell radiolabeling for human use.
Journal of Labelled Compounds and Radiopharmaceuticals.
64:209-216.
2021
|
|
| 2021
|
Global access to medical imaging and nuclear medicine
2021
|
|
| 2021
|
Synchronous Malignancies Identified by 18F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review.
Clinical Genitourinary Cancer.
19:e37-e40.
2021
|
|
| 2021
|
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
Journal of Alzheimer's Disease.
79:543-557.
2021
|
|
| 2021
|
Real-Time Gain Control of PET Detectors and Evaluation with Challenging Radionuclides.
IEEE Transactions on Medical Imaging.
40:71-80.
2021
|
|
| 2020
|
Dynamic 18F-FDOPA-PET/MRI for the preoperative evaluation of gliomas: Correlation with stereotactic histopathology.
Neuro-oncology practice.
7:656-667.
2020
|
|
| 2020
|
Measurement of blood flow in myocardial layers: A step toward comprehensive physiological evaluation.
Journal of Nuclear Cardiology.
27:1675-1678.
2020
|
|
| 2020
|
Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
ESC Heart Failure.
7:1676-1687.
2020
|
|
| 2020
|
FDG-PET/CT diagnosis of aortitis and pseudoaneurysms.
Journal of Nuclear Cardiology.
27:362-365.
2020
|
|
| 2020
|
The role of metabolic plasticity in blood and brain stem cell pathophysiology.
Cancer Research.
80:5-16.
2020
|
|
| 2019
|
Myocardial blood flow measures using cardiac positron emission tomography: Software comparisons.
Journal of Nuclear Cardiology.
26:2013-2017.
2019
|
|
| 2019
|
Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.
PLoS One.
14.
2019
|
|
| 2019
|
Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer.
Advances in Radiation Oncology.
4:649-658.
2019
|
|
| 2019
|
Recognizing and minimizing artifacts at ct, mri, us, and molecular imaging
2019
|
|
| 2019
|
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Workflow for Research and Clinical Brain PET Applications
2019
|
|
| 2019
|
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ 18 F]FDG: version 1.0.
European Journal of Nuclear Medicine and Molecular Imaging.
46:540-557.
2019
|
|
| 2019
|
Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.
Journal of the American College of Radiology.
16:315-320.
2019
|
|
| 2019
|
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.
Journal of Alzheimer's Disease.
70:1241-1257.
2019
|
|
| 2019
|
Current and future imaging methods for evaluating response to immunotherapy in neuro-oncology.
Theranostics.
9:5085-5104.
2019
|
|
| 2018
|
Imaging melphalan therapy response in preclinical extramedullary multiple myeloma with 18F-FDOPA and 18F-FDG PET.
Journal of Nuclear Medicine.
59:1551-1557.
2018
|
|
| 2018
|
Investigational PET tracers for high-grade gliomas
2018
|
|
| 2018
|
Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer.
Translational andrology and urology.
7:S462-S476.
2018
|
|
| 2018
|
18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.
Neuro-oncology practice.
5:28-36.
2018
|
|
| 2018
|
PET/MR Imaging in Head and Neck Cancer: Current Applications and Future Directions.
Magnetic Resonance Imaging Clinics of North America.
26:167-178.
2018
|
|
| 2018
|
Amino acid uptake measured by [ 18 F]AFETP increases in response to arginine starvation in ASS1-deficient sarcomas.
Theranostics.
8:2107-2116.
2018
|
|
| 2018
|
Practical Considerations for Clinical PET/MR Imaging.
PET Clinics.
13:97-112.
2018
|
|
| 2017
|
Lymph node imaging in initial staging of prostate cancer: An overview and update..
World Journal of Radiology.
9:389-399.
2017
|
|
| 2017
|
ACR and SNMMI Joint Credentialing Statement for PET/MRI of the Body..
Journal of Nuclear Medicine.
58:1174-1176.
2017
|
|
| 2017
|
Evaluation of attenuation correction in cardiac PET using PET/MR.
Journal of Nuclear Cardiology.
24:839-846.
2017
|
|
| 2017
|
Practical Considerations for Clinical PET/MR Imaging.
Magnetic Resonance Imaging Clinics of North America.
25:281-296.
2017
|
|
| 2017
|
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers..
Cell Reports.
18:991-1004.
2017
|
|
| 2017
|
Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein..
Nature Communications.
8:14152.
2017
|
|
| 2016
|
Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?.
Nuclear Medicine and Molecular Imaging.
50:292-299.
2016
|
|
| 2016
|
18F-Fluciclovine (FACBC) and its potential use for breast cancer imaging.
Journal of Nuclear Medicine.
57:1329-1330.
2016
|
|
| 2016
|
Conspicuity of FDG-Avid Osseous Lesions on PET/MRI Versus PET/CT: a Quantitative and Visual Analysis..
Nuclear Medicine and Molecular Imaging.
50:228-239.
2016
|
|
| 2016
|
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy..
JAMA Neurology.
73:1070-1077.
2016
|
|
| 2016
|
Clinical application of PET/MRI in oncology.
Journal of Magnetic Resonance Imaging.
44:265-276.
2016
|
|
| 2016
|
Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma
2016
|
|
| 2016
|
SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0..
Journal of Nuclear Medicine.
57:1316-1322.
2016
|
|
| 2016
|
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
2016
|
|
| 2016
|
Impact of MR-Based Attenuation Correction on Neurologic PET Studies..
Journal of Nuclear Medicine.
57:913-917.
2016
|
|
| 2016
|
Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
Journal of Medicinal Chemistry.
59:3515-3531.
2016
|
|
| 2016
|
PET/MRI: Emerging Clinical Applications in Oncology..
Academic Radiology.
23:220-236.
2016
|
|
| 2016
|
Multimodality Review of Amyloid-related Diseases of the Central Nervous System.
2016
|
|
| 2015
|
Synthesis and Biological Evaluation of (S)-Amino-2-methyl-4-[76Br]bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging.
Journal of Medicinal Chemistry.
58:8542-8552.
2015
|
|
| 2015
|
PET/MRI for the body imager: abdominal and pelvic oncologic applications..
Abdominal radiology (New York).
40:1387-1404.
2015
|
|
| 2015
|
Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors..
Journal of Medicinal Chemistry.
58:3817-3829.
2015
|
|
| 2015
|
Imaging biomarkers associated with cognitive decline: a review..
Biological Psychiatry.
77:685-692.
2015
|
|
| 2015
|
American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain..
Journal of Nuclear Medicine.
56:642-645.
2015
|
|
| 2015
|
Beyond whole-body imaging: Advanced imaging techniques of PET/MRI.
Clinical Nuclear Medicine.
40:e88-e95.
2015
|
|
| 2015
|
Facile purification and click labeling with 2-[18F]fluoroethyl azide using solid phase extraction cartridges.
2015
|
|
| 2015
|
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors..
Disease Markers.
2015:874904.
2015
|
|
| 2015
|
System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid..
Nuclear Medicine and Biology.
42:8-18.
2015
|
|
| 2014
|
Attenuation Effects of MR Headphones During Brain PET/MR Studies..
Journal of Nuclear Medicine Technology.
42:93-100.
2014
|
|
| 2014
|
An overview of nuclear medicine studies for urgent and emergent indications..
Seminars in Roentgenology.
49:210-224.
2014
|
|
| 2014
|
Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: A preliminary PET study.
Psychiatry Research.
221:231-239.
2014
|
|
| 2014
|
Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences..
Journal of Magnetic Resonance Imaging.
39:259-268.
2014
|
|
| 2014
|
Imaging evaluation of CSF shunts..
American Journal of Roentgenology.
202:38-53.
2014
|
|
| 2013
|
Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET.
PLoS One.
8.
2013
|
|
| 2013
|
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas..
Journal of Nuclear Medicine.
54:1120-1126.
2013
|
|
| 2013
|
Radiolabeled amino acids for oncologic imaging..
Journal of Nuclear Medicine.
54:1007-1010.
2013
|
|
| 2013
|
Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging..
Nuclear Medicine and Biology.
40:498-506.
2013
|
|
| 2013
|
Overview of PET Tracers for Brain Tumor Imaging..
PET Clinics.
8:129-146.
2013
|
|
| 2013
|
Advances in diagnostic testing for Alzheimer disease..
Missouri medicine.
110:401-405.
2013
|
|
| 2013
|
Fluorine-18 labeled amino acids for oncologic imaging with positron emission tomography..
Current Topics in Medicinal Chemistry.
13:871-891.
2013
|
|
| 2013
|
Nuclear medicine in the acute clinical setting: indications, imaging findings, and potential pitfalls.
2013
|
|
| 2012
|
Commentary.
2012
|
|
| 2012
|
Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents..
Medicinal Research Reviews.
32:868-905.
2012
|
|
| 2010
|
Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography..
Molecular Imaging.
9:329-342.
2010
|
|
| 2010
|
Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors..
Journal of Medicinal Chemistry.
53:876-886.
2010
|
|
| 2008
|
Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography..
Cancer and Metastasis Reviews.
27:555-573.
2008
|
|
| 2007
|
Preparation of antidepressants for use in preclinical research..
International Journal of Neuropsychopharmacology.
10:759-763.
2007
|
|
| 2006
|
Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET..
Journal of Medicinal Chemistry.
49:942-946.
2006
|
|
| 2005
|
Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies..
Applied Radiation and Isotopes.
63:353-361.
2005
|
|
| 2005
|
Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agents..
Nuclear Medicine and Biology.
32:593-605.
2005
|
|
| 2005
|
Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands..
Journal of Medicinal Chemistry.
48:4254-4265.
2005
|
|
| 2005
|
Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography..
Nuclear Medicine and Biology.
32:75-86.
2005
|
|
| 2004
|
Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter..
Nuclear Medicine and Biology.
31:705-718.
2004
|
|
| 2004
|
Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter..
Journal of Medicinal Chemistry.
47:1122-1135.
2004
|
|
| 2003
|
Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids..
Nuclear Medicine and Biology.
30:477-490.
2003
|
|
| 2003
|
Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis..
Applied Radiation and Isotopes.
58:657-666.
2003
|
|
| 2003
|
Stereochemistry in Drug Action..
The primary care companion for CNS disorders.
5:70-73.
2003
|
|
| 2003
|
Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography..
Journal of Medicinal Chemistry.
46:925-935.
2003
|
|
| 2002
|
Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid..
Journal of Medicinal Chemistry.
45:2240-2249.
2002
|
|
| 2002
|
Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection..
Journal of Medicinal Chemistry.
45:2250-2259.
2002
|
|
| 2001
|
Radioligands for PET and SPECT Imaging of the central noradrenergic system.
2001
|
|
